Literature DB >> 8186717

Myoblast transplantation between monozygotic twin girl carriers of Duchenne muscular dystrophy.

J P Tremblay1, J P Bouchard, F Malouin, D Théau, F Cottrell, H Collin, A Rouche, S Gilgenkrantz, N Abbadi, M Tremblay.   

Abstract

Monozygotic twin girls, both carriers of Duchenne muscular dystrophy, only one a severe symptomatic carrier and the other asymptomatic due to opposite lyonization, were studied. Myoblast clones were obtained from a muscle biopsy of the asymptomatic carrier. PCR amplification showed that most (94%) of these clones produced normal dystrophin mRNA. Roughly 704 million myoblasts were produced from 119 clones. These myoblasts were transplanted into the extensor carpi radialis (ECR) and in the biceps of one arm of the manifesting carrier while the other arm acted as the control. The strength of the patient was evaluated in a series of pre- and post-tests and a biopsy was obtained about 1 yr after the transplantation. The myoblast injections produced a significant force gain (12%-31%) in wrist extension but no force gain for elbow flexion. Muscle biopsies on the injected and control muscles obtained 1 yr after the injections showed only a small increase in the number of dystrophin positive fibers and the presence of numerous small type II fibers. The small beneficial effect of this transplantation cannot be attributed to immune problems, the donor and the recipient being identical twins, but may be due to a low level of spontaneous muscle regeneration.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8186717     DOI: 10.1016/0960-8966(93)90121-y

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  13 in total

1.  Sparing of extraocular muscle in aging and muscular dystrophies: a myogenic precursor cell hypothesis.

Authors:  Kristen M Kallestad; Sadie L Hebert; Abby A McDonald; Mark L Daniel; Sharon R Cu; Linda K McLoon
Journal:  Exp Cell Res       Date:  2011-01-27       Impact factor: 3.905

2.  A case for immunosuppression for myoblast transplantation in duchenne muscular dystrophy.

Authors:  Jacques P Tremblay; Daniel Skuk; Benjamino Palmieri; David M Rothstein
Journal:  Mol Ther       Date:  2009-07       Impact factor: 11.454

3.  Defining the heterogeneity of skeletal muscle-derived side and main population cells isolated immediately ex vivo.

Authors:  Kristen M Kallestad; Linda K McLoon
Journal:  J Cell Physiol       Date:  2010-03       Impact factor: 6.384

4.  Autologous myoblast transplantation for oculopharyngeal muscular dystrophy: a phase I/IIa clinical study.

Authors:  Sophie Périé; Capucine Trollet; Vincent Mouly; Valérie Vanneaux; Kamel Mamchaoui; Belaïd Bouazza; Jean Pierre Marolleau; Pascal Laforêt; Françoise Chapon; Bruno Eymard; Gillian Butler-Browne; Jérome Larghero; Jean Lacau St Guily
Journal:  Mol Ther       Date:  2013-07-08       Impact factor: 11.454

5.  * The Impact of Age on Skeletal Muscle Progenitor Cell Survival and Fate After Injury.

Authors:  Yu Zhou; Daniel Lovell; Maigen Bethea; Benyam Yoseph; James Poteracki; Shay Soker; Tracy Criswell
Journal:  Tissue Eng Part C Methods       Date:  2017-12       Impact factor: 3.056

6.  Recent developments in the treatment of Duchenne muscular dystrophy and spinal muscular atrophy.

Authors:  Wendy K M Liew; Peter B Kang
Journal:  Ther Adv Neurol Disord       Date:  2013-05       Impact factor: 6.570

7.  Dynamics of myoblast transplantation reveal a discrete minority of precursors with stem cell-like properties as the myogenic source.

Authors:  J R Beauchamp; J E Morgan; C N Pagel; T A Partridge
Journal:  J Cell Biol       Date:  1999-03-22       Impact factor: 10.539

8.  Transient immunosuppressive treatment leads to long-term retention of allogeneic myoblasts in hybrid myofibers.

Authors:  G K Pavlath; T A Rando; H M Blau
Journal:  J Cell Biol       Date:  1994-12       Impact factor: 10.539

Review 9.  Myogenic Precursors from iPS Cells for Skeletal Muscle Cell Replacement Therapy.

Authors:  Isart Roca; Jordi Requena; Michael J Edel; Ana Belén Alvarez-Palomo
Journal:  J Clin Med       Date:  2015-01-29       Impact factor: 4.241

Review 10.  Recent progress in satellite cell/myoblast engraftment -- relevance for therapy.

Authors:  Deborah Briggs; Jennifer E Morgan
Journal:  FEBS J       Date:  2013-04-24       Impact factor: 5.542

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.